Search / Trial NCT06612489

Efficacy of Biofeedback-Based Serious Game for Pain Alleviation in Middle-Aged and Older Ovarian Cancer Patients: A Randomized Controlled Trial

Launched by SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Sep 21, 2024

Trial Information

Current as of October 04, 2024

Completed

Keywords

Description

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * Meeting the diagnostic standards established by the International Association for the Study of Pain (IASP) and having a pain severity level between 3 and 6 (classified as mild to moderate) at the time of enrollment,
  • * Diagnosed with ovarian caner
  • * Demonstrating clear cognitive and expressive abilities,
  • * Being aged 45 or older,
  • * Providing voluntary consent after fully understanding the study's objectives.
  • Exclusion Criteria:
  • * Individuals with a history of mental illness or communication disorders,
  • * Those experiencing vision or cognitive impairments,
  • * Individuals undergoing pain medication treatment during the intervention period.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Shanghai, Shanghai, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0